Mirna Mcdonald

Teva Branded Pharmaceutical Products R&D Inc
Panama

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Reslizumab as add-on therapy in patients with refractory asthma.

Reslizumab as add-on therapy in patients with refractory asthma.

Journal: BMJ open respiratory research

Published: September 10, 2019

Effect of intravenously administered reslizumab on spirometric lung age in patients with moderate-to-severe eosinophilic asthma.

Effect of intravenously administered reslizumab on spirometric lung age in patients with moderate-to-severe eosinophilic asthma.

Journal: Allergy and asthma proceedings

Published: July 03, 2019

Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials.

Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 14, 2018

The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.

The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.

Journal: Headache

Published: October 09, 2018

Early decreases in blood eosinophil levels with reslizumab.

Early decreases in blood eosinophil levels with reslizumab.

Journal: The Journal of allergy and clinical immunology

Published: June 20, 2018

Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials.

Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials.

Journal: Cephalalgia : an international journal of headache

Published: May 04, 2018

Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects.

Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects.

Journal: British journal of clinical pharmacology

Published: January 17, 2018

Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.

Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.

Journal: The journal of allergy and clinical immunology. In practice

Published: October 18, 2017

Showing 1-8 of 8

Last Updated: 09/26/2026